Patent ID: 11912766
Assignee: ALLAKOS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 7:
8. The anti-Siglec-7 antibody of claim 7, wherein the variant Fc region comprises at least one amino acid selected from the group consisting of 232S, 233S, 242C, 252Y, 254T, 256E, 259C, 287C, 292C, 302C, 306C, 323C, 329G, 332C, and 334C, or
comprises at least two amino acids or at least three amino acids selected from the group consisting of 232S, 233S, 242C, 252Y, 254T, 256E, 259C, 287C, 292C, 302C, 306C, 323C, 329G, 332C, and 334C.